logo
#

Latest news with #RSPA

MIRASOL GENERAL MANAGER MATT LAMBERT NAMED 2025 FACILITY MANAGER OF THE YEAR
MIRASOL GENERAL MANAGER MATT LAMBERT NAMED 2025 FACILITY MANAGER OF THE YEAR

Yahoo

time3 days ago

  • Business
  • Yahoo

MIRASOL GENERAL MANAGER MATT LAMBERT NAMED 2025 FACILITY MANAGER OF THE YEAR

The award highlights Lambert's transformational impact on Mirasol's racquet sports programs, facilities, and team PALM BEACH GARDENS, Fla., June 5, 2025 /PRNewswire/ -- The Country Club at Mirasol is proud to announce that General Manager/COO Matt Lambert has been named the 2025 Facility Manager of the Year by the Racquet Sports Professional Association (RSPA), Florida Division. This prestigious award recognizes facility leaders who demonstrate exceptional commitment to the advancement of racquet sports within their facilities and the professionals who support them. Under Matt's direction, the Club's popular racquet sports program has flourished, with utilization of the racquet facilities increasing by 21% and 33% over the past two years. In 2025, instruction revenue is projected to exceed $900,000, and merchandise sales are expected to reach $650,000—testaments to the vibrancy and growth of the program. Additionally, his dedication to staff development and mentorship is second to none. He established a leadership program at Mirasol to help mid-level managers build core skills in budgeting, leadership, and career development, creating a culture of mentorship that extends beyond club boundaries. "I'm deeply honored to receive this recognition from the RSPA," said Lambert. "I'm especially grateful to Mirasol's Director of Sports, Jeremy Barker, and Director of Racquet Sports, Kristine Mendivil, whose vision and dedication have been instrumental in creating an outstanding racquet program for our active and engaged membership." In addition to overseeing a dedicated team and a thriving racquet program that includes 15 Har-Tru tennis courts and six newly added pickleball courts, Matt, with the support of the membership and Board of Directors, is leading the charge on a groundbreaking new facility: an 18,000-square-foot indoor pickleball complex featuring seven weather-proof regulation courts. This ambitious project is a key component of the Club's long-term vision to expand Mirasol's recreational offerings and ensure year-round access to high-quality play. Matt's accomplishments extend well beyond racquet sports. He oversaw the Club's $40 million expansion in 2016, which included the development of The Esplanade wellness facility, including fitness, spa, dining, and aquatics, and the flagship fine dining restaurant Solstice, among other award-winning amenities. His contributions to the hospitality industry have also been widely recognized. He was named Club Executive of the Year by the Club Managers Association of America in 2024, received the James H. Brewer Award for Excellence in Club Management, and was honored with the Stephen Elmont Alumni of the Year Award in 2020 from The Department of Hospitality and Tourism Management at the Isenberg School of Management University of Massachusetts Amherst. For more information about Mirasol and its racquet sports program, please visit About Mirasol: Mirasol is a gated community of 1,170 homes located north of PGA Boulevard in Palm Beach Gardens. The Country Club at Mirasol is a member-owned, private country club community whose purpose is to create uniquely satisfying golf, racquet sports, recreational, and social experiences for residents, their families, and guests in a welcoming atmosphere with outstanding personalized service and fiscally responsible management. Mirasol has been named one of America's Greatest Private Clubs, has been awarded Platinum Club of America and Distinguished Club status, is a designated Audubon Cooperative Sanctuary, and hosted the PGA's Honda Classic from 2003-2006. For more information, visit View original content to download multimedia: SOURCE The Country Club at Mirasol Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

AD Ports to receive Panamax-Class cranes for Safaga terminal
AD Ports to receive Panamax-Class cranes for Safaga terminal

Trade Arabia

time04-03-2025

  • Business
  • Trade Arabia

AD Ports to receive Panamax-Class cranes for Safaga terminal

AD Ports Group, an enabler of integrated trade, transport and logistics solutions, today announced it was preparing to receive three new state-of-the-art Panamax cranes from Shanghai Zhenhua Heavy Industries Co (ZPMC), ordered for the group's new multipurpose cargo terminal in Safaga, Egypt, which is expected to be operational in the second half of 2026. Under a 30-year concession agreement signed with the Red Sea Ports Authority (RSPA) in 2023, the group is developing and will operate a multi-purpose terminal in Safaga Port. AD Ports Group is investing AED193 million ($52.55 million) in three ship-to-shore (STS) cranes, and six hybrid rubber tyred gantry (RTG) cranes for Noatum Ports - Safaga Terminal, the company said. This is in addition to a contract for six ship-to-shore (STS) cranes, and 17 hybrid rubber tyred gantry (RTG) cranes awarded to ZPMC for a cost of over AED420 million to be deployed in terminal projects in New East Mole Terminal in Pointe Noire - Republic of the Congo, and Noatum Ports, Luanda Terminal in Angola as announced by AD Ports Group in September last year. The impending delivery of the cranes signals the start of final preparations for Noatum Ports - Safaga Terminal, following the appointment, in December last year, of Hassan Allam Construction, Egypt's leading engineering and construction company, to build the infrastructure of the multipurpose terminal on Egypt's Red Sea coast, which will be the first internationally operated port terminal in Upper Egypt region. The terminal's area includes erecting superstructure, equipment, buildings, and utilities to create advanced facilities and leading-edge infrastructure and handle diverse cargo including dry bulk, liquid bulk, containerised cargo and Ro-Ro vehicles. Noatum Ports - Safaga Terminal will encompass approximately 810,000 sq m, a 1,000-m quay wall, with container capacity of 450K TEUs , 5 million tonnes dry bulk and general cargo capacity, 1 million tonnes liquid bulk capacity, Ro-Ro facilities with 50K CEUs capacity, as well as common areas. The multiple facilities will include administration buildings, workshops, warehouses, and authority buildings, along with extensive infrastructure development including roads, utilities and security systems. The project will feature a 48,000 sq m concrete apron, an 80,354 sq m container terminal with supporting infrastructure, and approximately 66,360 sq m for general cargo and break-bulk operations. Ahmed Al Mutawa, AD Ports Group Regional CEO, said: 'Noatum Ports - Safaga Terminal will support Egypt's economic development with creation of the Red Sea region's most modern, efficient terminal facility, which will vastly improve the area's connectivity and lower costs for traders and businesses. We are committed to delivering on our agreement to realise this world-class facility with our Egyptian partners, the Egyptian Ministry of Transport and RSPA. Noatum Ports - Safaga Terminal is an important milestone in the development of our Group's growing ports and maritime strategy in Egypt, where we are taking a lead role through cruise, multipurpose and Ro-Ro concessions to lay a foundation for rapid growth.' The Safaga concession is part of a broader expansion into Egypt's Red Sea region, where the group also has concessions to operate three cruise passenger terminal in Safaga, Hurghada and Sharm El Sheikh, and has initialed agreements with Egyptian authorities to operate a passenger cruise terminal and a Ro-Ro terminal in Ain Sokhna, near the Red Sea mouth of the Suez Canal. Through its Egyptian maritime shipping lines, Transmar, TCI, and Safina B.V., the Group is also a major provider of connectivity to local and international clients, the company added. - TradeArabia News Service

Kiosk Association at HIMSS Healthcare Conference
Kiosk Association at HIMSS Healthcare Conference

Associated Press

time17-02-2025

  • Business
  • Associated Press

Kiosk Association at HIMSS Healthcare Conference

WESTMINSTER, Colo., Feb. 17, 2025 (SEND2PRESS NEWSWIRE) — Kiosk Association: Come see us in booth 3165 (HIMSS site) at the Venetian for the HIMSS Healthcare conference. Say hello, make connections and setup meeting. Patient check-in, accessibility tools for UX and usability, visitor registration and even wristband printers. We have a full portfolio of pictures, contacts and more on our Kiosk Industry page as well. We have international companies. The HIMSS link lets you connect and chat, or, you can email [email protected] — I won't be there but hopefully playing golf here in Denver. FEATURED This month we have our feature article 'Sports Betting, Bitcoin and Crypto Has its time come?' trends across Europe and the US. How to prepare for the revolution (sounds a bit dramatic, maybe), but it is a very reasonable probability. Bitcoin ATMs still have problems, for sure. On the not-so-good news side, we cover the withdrawal from the Federal Register of Accessible Kiosks NPRM. What next? We have decided that our best response is to assist the industry in developing our common usability guidelines so that all self-service is 'self-enabled.' Testing with personas is a significant component. COVERAGE We have a new affiliation with the RSPA, North America's largest community of VARs, software providers, vendors, and distributors in the retail, restaurant, grocery, and cannabis verticals. This expands our coverage. Jim Roddy, President of RSPA, 'The RSPA is happy to work with Kiosk Industry so together we can share insights and best practices with retail technology solution providers. We see the self-service trend continuing to escalate, and kiosks will play a big role making that happen.' There are international websites with an Asia-focused focus and a Europe-focused focus. See and For example, we are writing an article on latest first of its kind cutting-edge LED menu boards in Poland and KFC. Wayfinding – Case Study Philadephia Cash Watch – Diebold Nixdorf — Will It Adapt Fast Enough or Pull an NCR? Sports Betting, Bitcoin and Crypto – Has Its Time Come? NMI Payments Integration Self-Service Trends 2025 Accessibility ADA Disabilities ACT Status 2025 POS or Point of Sale Solution PCI Example KT Group – Kiosk Manufacturer FOR AV WE POST TO AVIXA Wayfinding Case Study Philadelphia Airport Can I Go To ISE Barcelona? Please! EV Charging and Healthcare Facilities Digital Podium – Yet Another 'Kiosk' Peerless-AV 2024 Projects of Note Best Self Service Awards for 2024 Contact [email protected] with questions or contacts. We accept no financial commission or paid advertising. It is free for companies to participate networking and insight. About Kiosk Industry: The source for experienced opinions, insider insights, news, and market trends. Learn from the experts. About the Kiosk Association: Our mission is to inform and educate. Thanks to the companies who make this possible. MEDIA CONTACT: Craig Keefner 720-324-1837 NEWS SOURCE: Kiosk Manufacturer Association Keywords: Point of Sale and Kiosks, Kiosk Association, Kiosk Industry, HIMSS Healthcare Conference, point of sale, kiosks, WESTMINSTER, Colo. Send2Press® Newswire. Information is believed accurate but not guaranteed. Story ID: S2P124100 AP-R15TBLLI

diaMentis reaches an important milestone in optimizing and accelerating the diagnosis of mental illnesses
diaMentis reaches an important milestone in optimizing and accelerating the diagnosis of mental illnesses

Associated Press

time05-02-2025

  • Business
  • Associated Press

diaMentis reaches an important milestone in optimizing and accelerating the diagnosis of mental illnesses

QUEBEC, Feb. 5, 2025 /PRNewswire/ - Holder of an innovative diagnostic support technology, recognized by the Food and Drug Administration (FDA) as a major scientific breakthrough, diaMentis unveils unprecedented results for the optimization and acceleration of mental illness diagnosis, marking a significant turning point for the Quebec-based company. Highlighted in the peer-reviewed international journal Biomedical Signal Processing and Control, diaMentis' study reveals previously unexplored areas of the retinal signal, and identifies new key factors to better differentiate mental disorders. This breakthrough will notably enable much more efficient diagnosis of mental illnesses, including schizophrenia and type 1 bipolar disorder. These results could be pivotal in driving a major paradigm shift in mental health management, significantly reducing the overall burden of institutional and community care. Provided that the necessary additional capital and resources are secured, diaMentis' innovative diagnostic support technology could be applied to other therapeutic fields that also need modernization. What the study reveals The study highlights the relevance of high-density retinal signals for deciphering biosignatures, as described in diaMentis' patent portfolio and patent applications. The study confirms the exceptional performances of diaMentis' prediction models and its patented RSPA® (retinal signal processing and analysis) concept. This system uses high-density retinal signals to build mathematical functions that predict whether a patient presents a pathological condition. The predictor mappings show that important classifiers are located in areas of the retinal signal that have never been studied before. This allows for extracting multiple biomarkers, spread across the entire dataset, unlike conventional ERG components that are rarer and less visible. The complete version of the study is available in Biomedical Signal Processing and Control. Addressing the challenges in diagnosing certain mental illnesses Scientists have long established that an accurate diagnosis in the early stages of a psychotic disorder is likely to lead to earlier relevant treatment with shorter duration of untreated psychosis episodes, which in turn will improve long-term functioning in most patients. Since symptoms may not yet be fully expressed at the onset of the illness, may develop slowly, and/or may overlap with other conditions, frequent misdiagnoses or long delays of five to ten years can occur, despite the high qualifications of clinicians, who are sometimes numerous specialists to be involved for a single patient123. In the United States, more than 57.8 million adults suffer from one of these diseases leading to more than 300 million medical consultations annually, and estimated mental health costing the US economy more than USD $280B annually45. In Canada, the incidence of adults experiencing significant symptoms of mental illness, and associated estimated healthcare system and economic impacts, are relatively similar to the US6. QUOTES 'The results of our study could be pivotal in driving a major paradigm shift in mental health management and significantly reducing the overall burden of institutional and community care. To the extent that the additional capital and resources needed are obtained, our breakthrough technology could be applied to other therapeutic areas that also need modernization.' - Normand Tremblay, President and CEO, diaMentis 'Over the past few months, the interim analysis of the clinical study results and the refinement of our mathematical models have led to exceptional outcomes. These results encourage us to continue our goal of transforming and modernizing the way patients with SZ and BP1 are diagnosed, thus enabling optimal management care.' - Claude Hariton, PhD, DSc. VP & Chief Scientific Officer (CSO) About diaMentis Arising from research conducted at Laval University, diaMentis holds intellectual property rights over retinal signal analysis and has an approved patent in the United States, with pending patent applications in several countries. The company has over 100 individual and institutional shareholders. Given the increasingly strong scientific evidence, diaMentis is now seeking to raise an additional USD $17.5 million, with $7.5 million allocated to the completion of its validation study at U.S. and Canadian clinical sites, and $10 million allocated to the completion of all aspects related to the industrialization of its solutions, including the continuation of its first wave of regulatory approvals in the U.S. and Canada.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store